CD4 +T cell depletion in human immunodeficiency virus (HIV) infection: Role of apoptosis

Viruses

Volumn 3, Issue 5, 2011, Pages 586-612

  Février, Michèle ^a   Dorgham, Karim ^b   Rebollo, Angelita ^b  

^a CNRS   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Apoptosis; HIV; Viral proteins

Indexed keywords

CD4 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NEF PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS ENVELOPE PROTEIN; VPR PROTEIN;

APOPTOSIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CYTOKINE PRODUCTION; CYTOPATHOGENIC EFFECT; GASTROINTESTINAL MUCOSA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSTIMULATION; INFLAMMATION; INTESTINE LYMPHATIC TISSUE; PATHOGENESIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; STEADY STATE; T CELL DEPLETION; TH17 CELL; VIREMIA; VIRUS REPLICATION;

ANIMALS; APOPTOSIS; CD4-POSITIVE T-LYMPHOCYTES; HIV INFECTIONS; HIV-1; HUMANS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 79957880451     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v3050586     Document Type: Review

References (173)

1. Baehrecke, E.H. How death shapes life during development. Nat. Rev. Mol. Cell Biol. 2002, 3, 779-787.
2. Brenner, D.; Mak, T.W. Mitochondrial cell death effectors. Curr. Opin. Cell Biol. 2009, 21, 871-877.
3. Strasser, A.; Jost, P.J.; Nagata, S. The many roles of FAS receptor signaling in the immune system. Immunity 2009, 30, 180-192.
4. Falschlehner, C.; Schaefer, U.; Walczak, H. Following TRAIL's path in the immune system. Immunology 2009, 127, 145-154.
5. Shedlock, D.J.; Hwang, D.; Choo, A.Y.; Chung, C.W.; Muthumani, K.; Weiner, D.B. HIV-1 viral genes and mitochondrial apoptosis. Apoptosis 2008, 13, 1088-1099.
6. Yang, Z.; Klionsky, D.J. Mammalian autophagy: core molecular machinery and signaling regulation. Curr. Opin. Cell Biol. 2010, 22, 124-131.
7. Eisenberg-Lerner, A.; Bialik, S.; Simon, H.U.; Kimchi, A. Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Differ. 2009, 16, 966-975.
8. Degterev, A.; Yuan, J. Expansion and evolution of cell death programmes. Nat. Rev. Mol. Cell Biol. 2008, 9, 378-390.
9. Krueger, A.; Fas, S.C.; Baumann, S.; Krammer, P.H. The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol. Rev. 2003, 193, 58-69.
10. Green, D.R.; Droin, N.; Pinkoski, M. Activation-induced cell death in T cells. Immunol. Rev. 2003, 193, 70-81.
11. Zhang, J.; Xu, X.; Liu, Y. Activation-induced cell death in T cells and autoimmunity. Cell. Mol. Immunol. 2004, 1, 186-192.
12. Krammer, P.H.; Arnold, R.; Lavrik, I.N. Life and death in peripheral T cells. Nat. Rev. Immunol. 2007, 7, 532-542.
13. Kaminskyy, V.; Zhivotovsky, B. To kill or be killed: how viruses interact with the cell death machinery. J. Intern. Med. 2010, 267, 473-482.
14. Cummins, N.W.; Badley, A.D. Mechanisms of HIV-associated lymphocyte apoptosis: 2010. Cell Death Dis. 2010, 1, e99.
15. Frankel, A.D.; Young, J.A. HIV-1: fifteen proteins and an RNA. Annu. Rev. Biochem. 1998, 67, 1-25.
16. Seelamgari, A.; Maddukuri, A.; Berro, R.; de la Fuente, C.; Kehn, K.; Deng, L.; Dadgar, S.; Bottazzi, M.E.; Ghedin, E.; Pumfery, A.; Kashanchi, F. Role of viral regulatory and accessory proteins in HIV-1 replication. Front. Biosci. 2004, 9, 2388-2413.
17. Dragic, T. An overview of the determinants of CCR5 and CXCR4 co-receptor function. J. Gen. Virol. 2001, 82, 1807-1814.
18. Berger, E.A.; Murphy, P.M.; Farber, J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 1999, 17, 657-700.
19. Dalgleish, A.G.; Beverley, P.C.; Clapham, P.R.; Crawford, D.H.; Greaves, M.F.; Weiss, R.A. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984, 312, 763-767.
20. Lifson, J.D.; Reyes, G.R.; McGrath, M.S.; Stein, B.S.; Engleman, E.G., AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen. Science 1986, 232, 1123-1127.
21. Cullen, B.R.; Greene, W.C. Regulatory pathways governing HIV-1 replication. Cell 1989, 58, 423-426.
22. Brenchley, J.M.; Schacker, T.W.; Ruff, L.E.; Price, D.A.; Taylor, J.H.; Beilman, G.J.; Nguyen, P.L.; Khoruts, A.; Larson, M.; Haase, A.T.; Douek, D.C. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 2004, 200, 749-759.
23. Mehandru, S.; Poles, M.A.; Tenner-Racz, K.; Horowitz, A.; Hurley, A.; Hogan, C.; Boden, D.; Racz, P.; Markowitz, M. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 2004, 200, 761-770.
24. Grossman, Z.; Meier-Schellersheim, M.; Paul, W. E.; Picker, L.J. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat. Med. 2006, 12, 289-295.
25. Klenerman, P.; Wu, Y.; Phillips, R. HIV: current opinion in escapology. Curr. Opin. Microbiol. 2002, 5, 408-413.
26. Casado, C.; Colombo, S.; Rauch, A.; Martinez, R.; Gunthard, H.F.; Garcia, S.; Rodriguez, C.; Del Romero, J.; Telenti, A.; Lopez-Galindez, C. Host and viral genetic correlates of clinical definitions of HIV-1 disease progression. PLoS ONE 2010, 5, e11079.
27. Pereyra, F.; Addo, M.M.; Kaufmann, D.E.; Liu, Y.; Miura, T.; Rathod, A.; Baker, B.; Trocha, A.; Rosenberg, R.; Mackey, E.; Ueda, P.; Lu, Z.; Cohen, D.; Wrin, T.; Petropoulos, C.J.; Rosenberg, E.S.; Walker, B.D. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J. Infect. Dis. 2008, 197, 563-571.
28. Okulicz, J.F.; Marconi, V.C.; Landrum, M.L.; Wegner, S.; Weintrob, A.; Ganesan, A.; Hale, B.; Crum-Cianflone, N.; Delmar, J.; Barthel, V.; Quinnan, G.; Agan, B.K.; Dolan, M.J. Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study. J. Infect. Dis. 2009, 200, 1714-1723.
29. Chomont, N.; El-Far, M.; Ancuta, P.; Trautmann, L.; Procopio, F.A.; Yassine-Diab, B.; Boucher, G.; Boulassel, M.R.; Ghattas, G.; Brenchley, J.M.; Schacker, T.W.; Hill, B.J.; Douek, D.C.; Routy, J.P.; Haddad, E.K.; Sekaly, R.P. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 2009, 15, 893-900.
30. Carter, C.C.; Onafuwa-Nuga, A.; McNamara, L.A.; Riddell, J.T.; Bixby, D.; Savona, M.R.; Collins, K.L. HIV-1 infects multipotent progenitor cells causing cell death and establishing latent cellular reservoirs. Nat. Med. 2010, 16, 446-451.
31. Orenstein, J.M.; Fox, C.; Wahl, S.M. Macrophages as a source of HIV during opportunistic infections. Science 1997, 276, 1857-1861.
32. Hazenberg, M.D.; Otto, S.A.; van Benthem, B.H.; Roos, M.T.; Coutinho, R.A.; Lange, J.M.; Hamann, D.; Prins, M.; Miedema, F. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. Aids 2003, 17, 1881-1888.
33. Hernandez, J.C.; Arteaga, J.; Paul, S.; Kumar, A.; Latz, E.; Urcuqui-Inchima, S. Up-Regulation of TLR2 and TLR4 in Dendritic Cells in Response to HIV Type 1 and Coinfection with Opportunistic Pathogens AIDS Res. Hum. Retroviruses. 2011, 27, doi:10.1089/aid.2010.0302.
34. Reed, M.; Cosgrove, J.M.; Cindrich, R.; Parithivel, V.S.; Gad, Y.; Bangalore, M.; Uzor, R.; Kalim, J.; Segura, R.; Albu, E. Ten years later: a single hospital experience with malignancy in HIV/AIDS. J. Surg. Oncol. 2010, 102, 282-286.
35. Brenchley, J.M.; Price, D.A.; Douek, D.C. HIV disease: Fallout from a mucosal catastrophe? Nat. Immunol. 2006, 7, 235-239.
36. Mosmann, T.R.; Cherwinski, H.; Bond, M.W.; Giedlin, M.A.; Coffman, R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986, 136, 2348-2357.
37. Zhu, J.; Paul, W.E. CD4 T cells: fates, functions, and faults. Blood 2008, 112, 1557-1569.
38. Blum, K.S.; Pabst, R. Lymphocyte numbers and subsets in the human blood. Do they mirror the situation in all organs? Immunol. Lett. 2007, 108, 45-51.
39. Pabst, R.; Russell, M.W.; Brandtzaeg, P. Tissue distribution of lymphocytes and plasma cells and the role of the gut. Trends. Immunol. 2008, 29, 206-208; author reply 209-210.
40. Anton, P.A.; Elliott, J.; Poles, M.A.; McGowan, I.M.; Matud, J.; Hultin, L.E.; Grovit-Ferbas, K.; Mackay, C.R.; Chen, I.S.Y.; Giorgi, J.V. Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue. Aids 2000, 14, 1761-1765.
41. Agace, W.W.; Roberts, A.I.; Wu, L.; Greineder, C.; Ebert, E.C.; Parker, C.M. Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation. Eur. J. Immunol. 2000, 30, 819-826.
42. Poles, M.A.; Elliott, J.; Taing, P.; Anton, P.A.; Chen, I.S. A preponderance of CCR5(+) CXCR4(+) mononuclear cells enhances gastrointestinal mucosal susceptibility to human immunodeficiency virus type 1 infection. J. Virol. 2001, 75, 8390-8399.
43. Zhu, J.; Yamane, H.; Paul, W.E. Differentiation of effector CD4 T cell populations (*). Annu. Rev. Immunol. 2010, 28, 445-489.
44. Lim, H.W.; Lee, J.; Hillsamer, P.; Kim, C.H. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J. Immunol. 2008, 180, 122-129.
45. Romagnani, S.; Maggi, E.; Liotta, F.; Cosmi, L.; Annunziato, F. Properties and origin of human Th17 cells. Mol. Immunol. 2009, 47, 3-7.
46. Romagnani, S. Human Th17 cells. Arthritis Res. Ther. 2008, 10, 206.
47. Bettelli, E.; Korn, T.; Oukka, M.; Kuchroo, V.K. Induction and effector functions of T(H)17 cells. Nature 2008, 453, 1051-1057.
48. Costantino, C.M.; Baecher-Allan, C.M.; Hafler, D.A. Human regulatory T cells and autoimmunity. Eur. J. Immunol. 2008, 38, 921-924.
49. Belkaid, Y. Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 2007, 7, 875-888.
50. Keynan, Y.; Card, C. M.; McLaren, P.J.; Dawood, M.R.; Kasper, K.; Fowke, K.R. The role of regulatory T cells in chronic and acute viral infections. Clin. Infect. Dis. 2008, 46, 1046-1052.
51. Fontenot, J.D.; Gavin, M.A.; Rudensky, A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003, 4, 330-336.
52. Hori, S.; Nomura, T.; Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299, 1057-1061.
53. Oswald-Richter, K.; Grill, S.M.; Shariat, N.; Leelawong, M.; Sundrud, M.S.; Haas, D.W.; Unutmaz, D. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol. 2004, 2, e198.
54. Booth, N.J.; McQuaid, A.J.; Sobande, T.; Kissane, S.; Agius, E.; Jackson, S.E.; Salmon, M.; Falciani, F.; Yong, K.; Rustin, M.H.; Akbar, A.N.; Vukmanovic-Stejic, M. Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO. J. Immunol. 2010, 184, 4317-4326.
55. Sakaguchi, S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000, 101, 455-458.
56. Curotto de Lafaille, M.A.; Lafaille, J.J. Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 2009, 30, 626-635.
57. Apostolou, I.; Sarukhan, A.; Klein, L.; von Boehmer, H. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 2002, 3, 756-763.
58. Apostolou, I.; von Boehmer, H. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 2004, 199, 1401-1408.
59. Workman, C.J.; Szymczak-Workman, A.L.; Collison, L.W.; Pillai, M.R.; Vignali, D.A. The development and function of regulatory T cells. Cell. Mol. Life Sci. 2009, 66, 2603-2622.
60. Zhou, X.; Bailey-Bucktrout, S.; Jeker, L.T.; Bluestone, J.A. Plasticity of CD4(+) FoxP3(+) T cells. Curr. Opin. Immunol. 2009, 21, 281-285.
61. Sempere, J.M.; Soriano, V.; Benito, J.M. T regulatory cells and HIV infection. AIDS Rev. 2007, 9, 54-60.
62. Murphy, K.M.; Stockinger, B. Effector T cell plasticity: flexibility in the face of changing circumstances. Nat. Immunol. 2010, 11, 674-680.
63. Duhen, T.; Geiger, R.; Jarrossay, D.; Lanzavecchia, A.; Sallusto, F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 2009, 10, 857-863.
64. Trifari, S.; Kaplan, C.D.; Tran, E.H.; Crellin, N.K.; Spits, H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat. Immunol. 2009, 10, 864-871.
65. Guadalupe, M.; Reay, E.; Sankaran, S.; Prindiville, T.; Flamm, J.; McNeil, A.; Dandekar, S. Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. J. Virol. 2003, 77, 11708-11717.
66. Cossarizza, A.; Ortolani, C.; Mussini, C.; Borghi, V.; Guaraldi, G.; Mongiardo, N.; Bellesia, E.; Franceschini, M.G.; De Rienzo, B.; Franceschi, C. Massive activation of immune cells with an intact T cell repertoire in acute human immunodeficiency virus syndrome. J. Infect. Dis. 1995, 172, 105-112.
67. Norris, P.J.; Pappalardo, B.L.; Custer, B.; Spotts, G.; Hecht, F.M.; Busch, M.P. Elevations in IL-10, TNF-alpha, and IFN-gamma from the earliest point of HIV Type 1 infection. AIDS Res. Hum. Retroviruses 2006, 22, 757-762.
68. Picker, L.J. Immunopathogenesis of acute AIDS virus infection. Curr. Opin. Immunol. 2006, 18, 399-405.
69. Estaquier, J.; Idziorek, T.; Zou, W.; Emilie, D.; Farber, C.M.; Bourez, J.M.; Ameisen, J.C. T helper type 1/T helper type 2 cytokines and T cell death: preventive effect of interleukin 12 on activation-induced and CD95 (FAS/APO-1)-mediated apoptosis of CD4+ T cells from human immunodeficiency virus-infected persons. J. Exp. Med. 1995, 182, 1759-1767.
70. Douek, D.C.; Brenchley, J.M.; Betts, M.R.; Ambrozak, D.R.; Hill, B.J.; Okamoto, Y.; Casazza, J.P.; Kuruppu, J.; Kunstman, K.; Wolinsky, S.; Grossman, Z.; Dybul, M.; Oxenius, A.; Price, D.A.; Connors, M.; Koup, R.A. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002, 417, 95-98.
71. Yue, F.Y.; Kovacs, C.M.; Dimayuga, R.C.; Gu, X.X.; Parks, P.; Kaul, R.; Ostrowski, M.A. Preferential apoptosis of HIV-1-specific CD4+ T cells. J. Immunol. 2005, 174, 2196-2204.
72. Pido-Lopez, J.; Imami, N.; Aspinall, R. Both age and gender affect thymic output: more recent thymic migrants in females than males as they age. Clin. Exp. Immunol. 2001, 125, 409-413.
73. Haynes, B.F.; Hale, L.P.; Weinhold, K.J.; Patel, D.D.; Liao, H.X.; Bressler, P.B.; Jones, D.M.; Demarest, J.F.; Gebhard-Mitchell, K.; Haase, A.T.; Bartlett, J.A. Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J. Clin. Invest. 1999, 103, 453-460.
74. Bandera, A.; Ferrario, G.; Saresella, M.; Marventano, I.; Soria, A.; Zanini, F.; Sabbatini, F.; Airoldi, M.; Marchetti, G.; Franzetti, F.; Trabattoni, D.; Clerici, M.; Gori, A. CD4+ T cell depletion, immune activation and increased production of regulatory T cells in the thymus of HIV-infected individuals. PLoS ONE 2010, 5, e10788.
75. de Oliveira Pinto, L.M.; Garcia, S.; Lecoeur, H.; Rapp, C.; Gougeon, M.L. Increased sensitivity of T lymphocytes to tumor necrosis factor receptor 1 (TNFR1)- and TNFR2-mediated apoptosis in HIV infection: relation to expression of Bcl-2 and active caspase-8 and caspase-3. Blood 2002, 99, 1666-1675.
76. Herbeuval, J.P.; Boasso, A.; Grivel, J.C.; Hardy, A.W.; Anderson, S.A.; Dolan, M.J.; Chougnet, C.; Lifson, J.D.; Shearer, G.M. TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells. Blood 2005, 105, 2458-2464.
77. Holm, G.H.; Zhang, C.; Gorry, P.R.; Peden, K.; Schols, D.; De Clercq, E.; Gabuzda, D. Apoptosis of bystander T cells induced by human immunodeficiency virus type 1 with increased envelope/receptor affinity and coreceptor binding site exposure. J. Virol. 2004, 78, 4541-4551.
78. Ahr, B.; Robert-Hebmann, V.; Devaux, C.; Biard-Piechaczyk, M. Apoptosis of uninfected cells induced by HIV envelope glycoproteins. Retrovirology 2004, 1, 12.
79. Finkel, T.H.; Tudor-Williams, G.; Banda, N.K.; Cotton, M.F.; Curiel, T.; Monks, C.; Baba, T.W.; Ruprecht, R. M.; Kupfer, A. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1995, 1, 129-134.
80. Pantaleo, G.; Graziosi, C.; Demarest, J.F.; Butini, L.; Montroni, M.; Fox, C.H.; Orenstein, J.M.; Kotler, D.P.; Fauci, A.S. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993, 362, 355-358.
81. Haase, A.T. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Annu. Rev. Immunol. 1999, 17, 625-656.
82. Mehandru, S.; Poles, M.A.; Tenner-Racz, K.; Manuelli, V.; Jean-Pierre, P.; Lopez, P.; Shet, A.; Low, A.; Mohri, H.; Boden, D.; Racz, P.; Markowitz, M. Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J. Virol. 2007, 81, 599-612.
83. Brenchley, J.M.; Knox, K.S.; Asher, A.I.; Price, D.A.; Kohli, L.M.; Gostick, E.; Hill, B.J.; Hage, C.A.; Brahmi, Z.; Khoruts, A.; Twigg, H.L., 3rd; Schacker, T.W.; Douek, D.C. High frequencies of polyfunctional HIV-specific T cells are associated with preservation of mucosal CD4 T cells in bronchoalveolar lavage. Mucosal Immunol. 2008, 1, 49-58.
84. Mattapallil, J.J.; Douek, D.C.; Hill, B.; Nishimura, Y.; Martin, M.; Roederer, M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005, 434, 1093-1097.
85. Chavez-Galan, L.; Arenas-Del Angel, M.C.; Zenteno, E.; Chavez, R.; Lascurain, R. Cell death mechanisms induced by cytotoxic lymphocytes. Cell Mol. Immunol. 2009, 6, 15-25.
86. Liu, Y.; McNevin, J.P.; Holte, S.; McElrath, M.J.; Mullins, J.I. Dynamics of viral evolution and CTL responses in HIV-1 infection. PLoS ONE 2011, 6, e15639.
87. Appay, V.; Papagno, L.; Spina, C.A.; Hansasuta, P.; King, A.; Jones, L.; Ogg, G.S.; Little, S.; McMichael, A.J.; Richman, D.D.; Rowland-Jones, S.L. Dynamics of T cell responses in HIV infection. J. Immunol. 2002, 168, 3660-3666.
88. Allen, T.M.; Altfeld, M.; Geer, S.C.; Kalife, E.T.; Moore, C.; O'Sullivan K M.; Desouza, I.; Feeney, M.E.; Eldridge, R.L.; Maier, E.L.; Kaufmann, D.E.; Lahaie, M.P.; Reyor, L.; Tanzi, G.; Johnston, M.N.; Brander, C.; Draenert, R.; Rockstroh, J.K.; Jessen, H.; Rosenberg, E.S.; Mallal, S.A.; Walker, B.D. Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution. J. Virol. 2005, 79, 13239-13249.
89. Jamieson, B.D.; Yang, O.O.; Hultin, L.; Hausner, M.A.; Hultin, P.; Matud, J.; Kunstman, K.; Killian, S.; Altman, J.; Kommander, K.; Korber, B.; Giorgi, J.; Wolinsky, S. Epitope escape mutation and decay of human immunodeficiency virus type 1-specific CTL responses. J. Immunol. 2003, 171, 5372-5379.
90. Ferri, K.F.; Jacotot, E.; Leduc, P.; Geuskens, M.; Ingber, D.E.; Kroemer, G. Apoptosis of syncytia induced by the HIV-1-envelope glycoprotein complex: influence of cell shape and size. Exp. Cell Res. 2000, 261, 119-126.
91. Perfettini, J.L.; Castedo, M.; Roumier, T.; Andreau, K.; Nardacci, R.; Piacentini, M.; Kroemer, G. Mechanisms of apoptosis induction by the HIV-1 envelope. Cell Death Differ. 2005, 12, 916-923.
92. Perfettini, J.L.; Nardacci, R.; Bourouba, M.; Subra, F.; Gros, L.; Seror, C.; Manic, G.; Rosselli, F.; Amendola, A.; Masdehors, P.; Chessa, L.; Novelli, G.; Ojcius, D.M.; Siwicki, J.K.; Chechlinska, M.; Auclair, C.; Regueiro, J.R.; de The, H.; Gougeon, M.L.; Piacentini, M.; Kroemer, G. Critical involvement of the ATM-dependent DNA damage response in the apoptotic demise of HIV-1-elicited syncytia. PLoS ONE 2008, 3, e2458.
93. Rivera-Toledo, E.; Lopez-Balderas, N.; Huerta, L.; Lamoyi, E.; Larralde, C. Decreased CD4 and wide-ranging expression of other immune receptors after HIV-envelope-mediated formation of syncytia in vitro. Arch. Virol. 2010, 155, 1205-1216.
94. Sodora, D.L.; Silvestri, G. Immune activation and AIDS pathogenesis. Aids 2008, 22, 439-446.
95. Prendergast, A.; Prado, J.G.; Kang, Y.H.; Chen, F.; Riddell, L.A.; Luzzi, G.; Goulder, P.; Klenerman, P. HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells. Aids 2010, 24, 491-502.
96. Brenchley, J.M.; Price, D.A.; Schacker, T.W.; Asher, T.E.; Silvestri, G.; Rao, S.; Kazzaz, Z.; Bornstein, E.; Lambotte, O.; Altmann, D.; Blazar, B.R.; Rodriguez, B.; Teixeira-Johnson, L.; Landay, A.; Martin, J.N.; Hecht, F.M.; Picker, L.J.; Lederman, M.M.; Deeks, S.G.; Douek, D.C. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006, 12, 1365-1371.
97. Maloy, K.J.; Kullberg, M.C. IL-23 and Th17 cytokines in intestinal homeostasis. Mucosal Immunol. 2008, 1, 339-349.
98. Brenchley, J.M.; Paiardini, M.; Knox, K.S.; Asher, A.I.; Cervasi, B.; Asher, T.E.; Scheinberg, P.; Price, D.A.; Hage, C.A.; Kholi, L.M.; Khoruts, A.; Frank, I.; Else, J.; Schacker, T.; Silvestri, G.; Douek, D.C. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008, 112, 2826-2835.
99. El Hed, A.; Khaitan, A.; Kozhaya, L.; Manel, N.; Daskalakis, D.; Borkowsky, W.; Valentine, F.; Littman, D.R.; Unutmaz, D. Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection. J. Infect. Dis. 2010, 201, 843-854.
100. Cosmi, L.; De Palma, R.; Santarlasci, V.; Maggi, L.; Capone, M.; Frosali, F.; Rodolico, G.; Querci, V.; Abbate, G.; Angeli, R.; Berrino, L.; Fambrini, M.; Caproni, M.; Tonelli, F.; Lazzeri, E.; Parronchi, P.; Liotta, F.; Maggi, E.; Romagnani, S.; Annunziato, F. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J. Exp. Med. 2008, 205, 1903-1916.
101. Hofer, U.; Speck, R.F. Disturbance of the gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection. Semin. Immunopathol. 2009, 31, 257-266.
102. Krammer, P.H. CD95's deadly mission in the immune system. Nature 2000, 407, 789-795.
103. Doitsh, G.; Cavrois, M.; Lassen, K.G.; Zepeda, O.; Yang, Z.; Santiago, M.L.; Hebbeler, A.M.; Greene, W.C. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 2010, 143, 789-801.
104. Kamata, M.; Nagaoka, Y.; Chen, I.S. Reassessing the role of APOBEC3G in human immunodeficiency virus type 1 infection of quiescent CD4+ T-cells. PLoS Pathog. 2009, 5, e1000342.
105. Zhou, Y.; Zhang, H.; Siliciano, J.D.; Siliciano, R.F. Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells. J. Virol. 2005, 79, 2199-2210.
106. Miura, Y.; Koyanagi, Y. Death ligand-mediated apoptosis in HIV infection. Rev. Med. Virol. 2005, 15, 169-178.
107. Gasper-Smith, N.; Crossman, D.M.; Whitesides, J.F.; Mensali, N.; Ottinger, J.S.; Plonk, S.G.; Moody, M.A.; Ferrari, G.; Weinhold, K.J.; Miller, S.E.; Reich, C.F., 3rd; Qin, L.; Self, S.G.; Shaw, G.M.; Denny, T.N.; Jones, L.E.; Pisetsky, D.S.; Haynes, B.F. Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design. J. Virol. 2008, 82, 7700-7710.
108. Herbeuval, J.P.; Nilsson, J.; Boasso, A.; Hardy, A.W.; Vaccari, M.; Cecchinato, V.; Valeri, V.; Franchini, G.; Andersson, J.; Shearer, G.M. HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques. Aids 2009, 23, 35-40.
109. Wang, R.; Brunner, T.; Zhang, L.; Shi, Y. Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expression. Oncogene 1998, 17, 1503-1508.
110. Oberg, H.H.; Lengl-Janssen, B.; Kabelitz, D.; Janssen, O. Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype. Cell. Immunol. 1997, 181, 93-100.
111. Ledru, E.; Lecoeur, H.; Garcia, S.; Debord, T.; Gougeon, M.L. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis. J. Immunol. 1998, 160, 3194-3206.
112. Zhang, X.R.; Zhang, L.Y.; Devadas, S.; Li, L.; Keegan, A.D.; Shi, Y.F. Reciprocal expression of TRAIL and CD95L in Th1 and Th2 cells: role of apoptosis in T helper subset differentiation. Cell Death Differ. 2003, 10, 203-210.
113. Aillet, F.; Masutani, H.; Elbim, C.; Raoul, H.; Chene, L.; Nugeyre, M.T.; Paya, C.; Barre-Sinoussi, F.; Gougerot-Pocidalo, M.A.; Israel, N. Human immunodeficiency virus induces a dual regulation of Bcl-2, resulting in persistent infection of CD4(+) T- or monocytic cell lines. J. Virol. 1998, 72, 9698-9705.
114. Fernandez Larrosa, P.N.; Croci, D.O.; Riva, D.A.; Bibini, M.; Luzzi, R.; Saracco, M.; Mersich, S.E.; Rabinovich, G.A.; Martinez Peralta, L. Apoptosis resistance in HIV-1 persistently-infected cells is independent of active viral replication and involves modulation of the apoptotic mitochondrial pathway. Retrovirology 2008, 5, 19.
115. Denning, T.L.; Wang, Y.C.; Patel, S.R.; Williams, I.R.; Pulendran, B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat. Immunol. 2007, 8, 1086-1094.
116. Vukmanovic-Stejic, M.; Zhang, Y.; Cook, J.E.; Fletcher, J.M.; McQuaid, A.; Masters, J.E.; Rustin, M.H.; Taams, L.S.; Beverley, P.C.; Macallan, D.C.; Akbar, A.N. Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo. J. Clin. Invest. 2006, 116, 2423-2433.
117. Akbar, A.N.; Vukmanovic-Stejic, M.; Taams, L.S.; Macallan, D.C. The dynamic co-evolution of memory and regulatory CD4+ T cells in the periphery. Nat. Rev. Immunol. 2007, 7, 231-237.
118. Nakamura, K.; Kitani, A.; Fuss, I.; Pedersen, A.; Harada, N.; Nawata, H.; Strober, W. TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice. J. Immunol. 2004, 172, 834-842.
119. Grossman, W.J.; Verbsky, J.W.; Tollefsen, B.L.; Kemper, C.; Atkinson, J.P.; Ley, T.J. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 2004, 104, 2840-2848.
120. Vignali, D.A.; Collison, L.W.; Workman, C.J. How regulatory T cells work. Nat. Rev. Immunol. 2008, 8, 523-532.
121. Vercoulen, Y.; Wehrens, E.J.; van Teijlingen, N.H.; de Jager, W.; Beekman, J.M.; Prakken, B.J. Human regulatory T cell suppressive function is independent of apoptosis induction in activated effector T cells. PLoS ONE 2009, 4, e7183.
122. Jiao, Y.; Fu, J.; Xing, S.; Fu, B.; Zhang, Z.; Shi, M.; Wang, X.; Zhang, J.; Jin, L.; Kang, F.; Wu, H.; Wang, F.S. The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8+ T cells in HIV-1-infected typical progressors, but not in long-term non-progressors. Immunology 2009, 128, e366-375.
123. Ji, J.; Cloyd, M.W. HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression. Int. Immunol. 2009, 21, 283-294.
124. Antons, A.K.; Wang, R.; Oswald-Richter, K.; Tseng, M.; Arendt, C.W.; Kalams, S.A.; Unutmaz, D. Naive precursors of human regulatory T cells require FoxP3 for suppression and are susceptible to HIV infection. J. Immunol. 2008, 180, 764-773.
125. Xing, S.; Fu, J.; Zhang, Z.; Gao, Y.; Jiao, Y.; Kang, F.; Zhang, J.; Zhou, C.; Wu, H.; Wang, F.S. Increased turnover of FoxP3high regulatory T cells is associated with hyperactivation and disease progression of chronic HIV-1 infection. J. Acquir. Immune Defic. Syndr. 2010, 54, 455-462.
126. Fritzsching, B.; Oberle, N.; Eberhardt, N.; Quick, S.; Haas, J.; Wildemann, B.; Krammer, P. H.; Suri-Payer, E. In contrast to effector T cells, CD4+CD25+FoxP3+ regulatory T cells are highly susceptible to CD95 ligand- but not to TCR-mediated cell death. J. Immunol. 2005, 175, 32-36.
127. Fritzsching, B.; Oberle, N.; Pauly, E.; Geffers, R.; Buer, J.; Poschl, J.; Krammer, P.; Linderkamp, O.; Suri-Payer, E. Naive regulatory T cells: a novel subpopulation defined by resistance toward CD95L-mediated cell death. Blood 2006, 108, 3371-3378.
128. Chase, A.J.; Yang, H.C.; Zhang, H.; Blankson, J.N.; Siliciano, R.F. Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation. J. Virol. 2008, 82, 8307-8315.
129. Epple, H.J.; Loddenkemper, C.; Kunkel, D.; Troger, H.; Maul, J.; Moos, V.; Berg, E.; Ullrich, R.; Schulzke, J.D.; Stein, H.; Duchmann, R.; Zeitz, M.; Schneider, T. Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 2006, 108, 3072-3078.
130. Nilsson, J.; Boasso, A.; Velilla, P.A.; Zhang, R.; Vaccari, M.; Franchini, G.; Shearer, G.M.; Andersson, J.; Chougnet, C. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 2006, 108, 3808-3817.
131. Fazekas de St Groth, B.; Landay, A.L. Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response? Aids 2008, 22, 671-683.
132. Mir, K.D.; Gasper, M.A.; Sundaravaradan, V.; Sodora, D.L. SIV infection in natural hosts: resolution of immune activation during the acute-to-chronic transition phase. Microbes. Infect. 2011, 13, 14-24.
133. Cossarizza, A. Apoptosis and HIV infection: about molecules and genes. Curr. Pharm. Des. 2008, 14, 237-244.
134. Vlahakis, S.R.; Algeciras-Schimnich, A.; Bou, G.; Heppelmann, C.J.; Villasis-Keever, A.; Collman, R.C.; Paya, C.V. Chemokine-receptor activation by env determines the mechanism of death in HIV-infected and uninfected T lymphocytes. J. Clin. Invest. 2001, 107, 207-215.
135. Somma, F.; Tuosto, L.; Gilardini Montani, M.S.; Di Somma, M.M.; Cundari, E.; Piccolella, E. Engagement of CD4 before TCR triggering regulates both Bax- and Fas (CD95)-mediated apoptosis. J. Immunol. 2000, 164, 5078-5087.
136. Roggero, R.; Robert-Hebmann, V.; Harrington, S.; Roland, J.; Vergne, L.; Jaleco, S.; Devaux, C.; Biard-Piechaczyk, M. Binding of human immunodeficiency virus type 1 gp120 to CXCR4 induces mitochondrial transmembrane depolarization and cytochrome c-mediated apoptosis independently of Fas signaling. J. Virol. 2001, 75, 7637-7650.
137. Denizot, M.; Varbanov, M.; Espert, L.; Robert-Hebmann, V.; Sagnier, S.; Garcia, E.; Curriu, M.; Mamoun, R.; Blanco, J.; Biard-Piechaczyk, M. HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells. Autophagy 2008, 4, 998-1008.
138. Espert, L.; Varbanov, M.; Robert-Hebmann, V.; Sagnier, S.; Robbins, I.; Sanchez, F.; Lafont, V.; Biard-Piechaczyk, M. Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection. PLoS ONE 2009, 4, e5787.
139. Caby, M. P.; Lankar, D.; Vincendeau-Scherrer, C.; Raposo, G.; Bonnerot, C. Exosomal-like vesicles are present in human blood plasma. Int. Immunol. 2005, 17, 879-887.
140. Zauli, G.; Gibellini, D.; Secchiero, P.; Dutartre, H.; Olive, D.; Capitani, S.; Collette, Y. Human immunodeficiency virus type 1 Nef protein sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway. Blood 1999, 93, 1000-1010.
141. Xu, X.N.; Laffert, B.; Screaton, G.R.; Kraft, M.; Wolf, D.; Kolanus, W.; Mongkolsapay, J.; McMichael, A.J.; Baur, A.S. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J. Exp. Med. 1999, 189, 1489-1496.
142. James, C.O.; Huang, M.B.; Khan, M.; Garcia-Barrio, M.; Powell, M.D.; Bond, V.C. Extracellular Nef protein targets CD4+ T cells for apoptosis by interacting with CXCR4 surface receptors. J. Virol. 2004, 78, 3099-3109.
143. Raymond, A.D.; Campbell-Sims, T.C.; Khan, M.; Lang, M.; Huang, M.B.; Bond, V.C.; Powell, M.D. HIV Type 1 Nef Is Released from Infected Cells in CD45(+) Microvesicles and Is Present in the Plasma of HIV-Infected Individuals. AIDS Res. Hum. Retroviruses 2011, 27, 167-178.
144. Lenassi, M.; Cagney, G.; Liao, M.; Vaupotic, T.; Bartholomeeusen, K.; Cheng, Y.; Krogan, N.J.; Plemenitas, A.; Peterlin, B.M. HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells. Traffic 2010, 11, 110-122.
145. Rasola, A.; Gramaglia, D.; Boccaccio, C.; Comoglio, P.M. Apoptosis enhancement by the HIV-1 Nef protein. J. Immunol. 2001, 166, 81-88.
146. Frankel, A.D.; Pabo, C.O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988, 55, 1189-1193.
147. Wang, H.; Zhong, C.Y.; Wu, J.F.; Huang, Y.B.; Liu, C.B. Enhancement of TAT cell membrane penetration efficiency by dimethyl sulphoxide. J. Control. Release 2010, 143, 64-70.
148. Gougeon, M.L. Apoptosis as an HIV strategy to escape immune attack. Nat. Rev. Immunol. 2003, 3, 392-404.
149. McCloskey, T.W.; Ott, M.; Tribble, E.; Khan, S.A.; Teichberg, S.; Paul, M.O.; Pahwa, S.; Verdin, E.; Chirmule, N. Dual role of HIV Tat in regulation of apoptosis in T cells. J. Immunol. 1997, 158, 1014-1019.
150. Li, C.J.; Friedman, D.J.; Wang, C.; Metelev, V.; Pardee, A.B. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 1995, 268, 429-431.
151. Dabrowska, A.; Kim, N.; Aldovini, A. Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes. J. Immunol. 2008, 181, 8460-8477.
152. Kim, N.; Kukkonen, S.; Gupta, S.; Aldovini, A. Association of Tat with promoters of PTEN and PP2A subunits is key to transcriptional activation of apoptotic pathways in HIV-infected CD4+ T cells. PLoS Pathog. 2010, 6, e1001103.
153. Zhang, S.M.; Sun, Y.; Fan, R.; Xu, Q.Z.; Liu, X.D.; Zhang, X.; Wang, Y.; Zhou, P.K. HIV-1 Tat regulates cyclin B1 by promoting both expression and degradation. FASEB J. 2010, 24, 495-503.
154. Sastry, K.J.; Marin, M.C.; Nehete, P.N.; McConnell, K.; el-Naggar, A.K.; McDonnell, T.J. Expression of human immunodeficiency virus type I tat results in down-regulation of bcl-2 and induction of apoptosis in hematopoietic cells. Oncogene 1996, 13, 487-493.
155. Bartz, S.R.; Emerman, M. Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8. J. Virol. 1999, 73, 1956-1963.
156. Strack, P.R.; Frey, M.W.; Rizzo, C.J.; Cordova, B.; George, H.J.; Meade, R.; Ho, S.P.; Corman, J.; Tritch, R.; Korant, B.D. Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 9571-9576.
157. Nie, Z.; Bren, G.D.; Vlahakis, S.R.; Schimnich, A.A.; Brenchley, J.M.; Trushin, S.A.; Warren, S.; Schnepple, D.J.; Kovacs, C.M.; Loutfy, M.R.; Douek, D.C.; Badley, A.D. Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo. J. Virol. 2007, 81, 6947-6956.
158. Morellet, N.; Roques, B.P.; Bouaziz, S. Structure-function relationship of Vpr: Biological implications. Curr. HIV Res. 2009, 7, 184-210.
159. Muthumani, K.; Hwang, D.S.; Desai, B.M.; Zhang, D.; Dayes, N.; Green, D.R.; Weiner, D.B. HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells. J. Biol. Chem. 2002, 277, 37820-37831.
160. Andersen, J.L.; DeHart, J.L.; Zimmerman, E.S.; Ardon, O.; Kim, B.; Jacquot, G.; Benichou, S.; Planelles, V. HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT. PLoS Pathog. 2006, 2, e127.
161. Arokium, H.; Kamata, M.; Chen, I. Virion-associated Vpr of human immunodeficiency virus type 1 triggers activation of apoptotic events and enhances fas-induced apoptosis in human T cells. J. Virol. 2009, 83, 11283-11297.
162. Gordon, S.N.; Cervasi, B.; Odorizzi, P.; Silverman, R.; Aberra, F.; Ginsberg, G.; Estes, J.D.; Paiardini, M.; Frank, I.; Silvestri, G. Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals. J. Immunol. 2010, 185, 5169-5179.
163. Battegay, M.; Nuesch, R.; Hirschel, B.; Kaufmann, G.R. Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infect. Dis. 2006, 6, 280-287.
164. d'Ettorre, G.; Paiardini, M.; Zaffiri, L.; Andreotti, M.; Ceccarelli, G.; Rizza, C.; Indinnimeo, M.; Vella, S.; Mastroianni, C.M.; Silvestri, G.; Vullo, V. HIV Persistence in the Gut Mucosa of HIV-Infected Subjects Undergoing Antiretroviral Therapy Correlates with Immune Activation and Increased Levels of LPS. Curr. HIV Res. 2011.
165. Chege, D.; Sheth, P.M.; Kain, T.; Kim, C.J.; Kovacs, C.; Loutfy, M.; Halpenny, R.; Kandel, G.; Chun, T. W.; Ostrowski, M.; Kaul, R. Sigmoid Th17 populations, the HIV latent reservoir, and microbial translocation in men on long-term antiretroviral therapy. Aids 2011, 25, 741-749.
166. Okulicz, J.F.; Lambotte, O. Epidemiology and clinical characteristics of elite controllers. Curr. Opin. HIV AIDS 2011, 6, 163-168.
167. Autran, B.; Descours, B.; Avettand-Fenoel, V.; Rouzioux, C. Elite controllers as a model of functional cure. Curr. Opin. HIV AIDS 2011, 6, 181-187.
168. Brandt, L.; Benfield, T.; Mens, H.; Clausen, L.N.; Katzenstein, T.L.; Fomsgaard, A.; Karlsson, I. Low level of regulatory T-cells and maintenance of balance between regulatory T-cells and TH17 cells in HIV-1-infected Elite Controllers. J. Acquir. Immune Defic. Syndr. 2011, doi:10.1097/QAI.0b013e318215a991.
169. Hersperger, A.R.; Martin, J.N.; Shin, L.Y.; Sheth, P.M.; Kovacs, C.M.; Cosma, G.L.; Makedonas, G.; Pereyra, F.; Walker, B.D.; Kaul, R.; Deeks, S.G.; Betts, M.R. Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression. Blood 2011, 117, 3799-3808.
170. Rabi, S.A.; O'Connell, K.A.; Nikolaeva, D.; Bailey, J.R.; Jilek, B.L.; Shen, L.; Page, K.R.; Siliciano, R.F.; Blankson, J.N. Unstimulated primary CD4+ T cells from HIV-1-positive elite suppressors are fully susceptible to HIV-1 entry and productive infection. J. Virol. 2011, 85, 979-986.
171. Lopez, M.; Soriano, V.; Peris-Pertusa, A.; Rallon, N.; Restrepo, C.; Benito, J.M. Elite controllers display higher activation on central memory CD8 T cells than HIV patients successfully on HAART. AIDS Res. Hum. Retroviruses 2011, 27, 157-165.
172. Ciccone, E.J.; Greenwald, J.H.; Lee, P.I.; Biancotto, A.; Read, S.W.; Yao, M.A.; Hodge, J.N.; Thompson, W.L.; Kovacs, S.B.; Chairez, C.L.; Migueles, S.A.; Kovacs, J.A.; Margolis, L. B.; Sereti, I. CD4+ T Cells, Including Th17 and Cycling Subsets, are Intact in the Gut Mucosa of HIV-1 Infected Long-Term Non- Progressors. J. Virol. 2011, doi: 10.1128/JVI.02643-10.
173. Cambiano, V.; Rodger, A.J.; Phillips, A.N. 'Test-and-treat': the end of the HIV epidemic? Curr. Opin. Infect. Dis. 2011, 24, 19-26.